USPSTF2023EN
Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement.
Zusammenfassung
US PREVENTIVE SERVICES TASK FORCE RECOMMENDATION STATEMENT
TITLE: Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement.
PUBLICATION: JAMA, 2023
PMID: 37526713
RECOMMENDATION SUMMARY:
Neural tube defects are among the most common congenital malformations in the US, with an estimated 3000 pregnancies affected each year. Many of these neural tube defects are caused by low folate levels in the body.
The US Preventive
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
USPSTF2017
Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.
USPSTF2023
USPSTF: Folic Acid Supplementation to Prevent Neural Tube Defects (Grade A, 2023)
USPSTF2023
USPSTF: Folic Acid Supplementation (Grade A)
USPSTF2024
Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
USPSTF2021
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.
USPSTF2018
Screening for Syphilis Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.
USPSTF2019
Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement.
Cochrane2019